PW Medtech Group Limited (HKG:1358)
Hong Kong
· Delayed Price · Currency is HKD 1.130
+0.060 (5.61%)
Jun 13, 2025, 4:08 PM HKT
PW Medtech Group Revenue
In the year 2024, PW Medtech Group had annual revenue of 768.90M CNY with 13.90% growth. PW Medtech Group had revenue of 430.49M in the half year ending December 31, 2024, with 33.45% growth.
Revenue
768.90M CNY
Revenue Growth
+13.90%
P/S Ratio
2.05
Revenue / Employee
543.39K CNY
Employees
1,415
Market Cap
1.68B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 768.90M | 93.82M | 13.90% |
| Dec 31, 2023 | 675.08M | 138.26M | 25.75% |
| Dec 31, 2022 | 536.83M | 265.43M | 97.80% |
| Dec 31, 2021 | 271.40M | 24.05M | 9.72% |
| Dec 31, 2020 | 247.35M | -114.83M | -31.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.49B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| Innovent Biologics | 10.03B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sino Biopharmaceutical | 30.72B |
| Akeso | 2.26B |